Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE2A | O00408 | 1/20 | 0.37 |
| ▸ | DRD2 | P14416 | 8/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | ALK | Q9UM73 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.32 |
| ▸ | CAMKK2 | Q96RR4 | 1/20 | 0.32 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.32 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.32 |
| ▸ | HTR6 | P50406 | 2/20 | 0.32 |
| ▸ | ESR1 | P03372 | 1/20 | 0.32 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.32 |
| ▸ | HTR2C | P28335 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30984048 | 0.94 | PDE2A (0.38) | PDE2ADRD2KDM4EALDH1A1ALK | |
| SCHEMBL31268937 | 0.94 | PDE2A (0.36) | PDE2ADRD2KDM4EALDH1A1ALK | |
| SCHEMBL31268825 | 0.93 | PDE2A (0.36) | PDE2ADRD2KDM4EALDH1A1ALK | |
| SCHEMBL31269256 | 0.91 | DRD2 (0.39) | PDE2ADRD2KDM4EALDH1A1ALK | |
| SCHEMBL30983467 | 0.89 | PDE2A (0.38) | PDE2ADRD2KDM4EALDH1A1ALK | |
| SCHEMBL30983569 | 0.87 | PDE2A (0.37) | PDE2ADRD2KDM4EALDH1A1ALK | |
| SCHEMBL30983551 | 0.87 | PDE2A (0.37) | PDE2ADRD2KDM4EALDH1A1ALK | |
| SCHEMBL31269142 | 0.86 | PDE2A (0.38) | PDE2ADRD2KDM4EALDH1A1ALK | |
| SCHEMBL31269308 | 0.86 | PDE2A (0.38) | PDE2ADRD2KDM4EALDH1A1ALK | |
| SCHEMBL31269262 | 0.86 | PDE2A (0.38) | PDE2ADRD2KDM4EALDH1A1ALK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4689155-A1 | USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS | Astrazeneca AB (SE) | 2026-02-11 | — | — | EP | disclosed |
| WO-2024201368-A1 | USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS | ASTRAZENECA AB (SE) | 2024-10-03 | — | — | WO | disclosed |